Basic Info
Title/Position: Full Professor; Head of Cancer Research & Nanomedicine Laboratory; Director of the Cancer Biology Research Center; Director of the TAU Kahn 3D BioPrinting Initiative
Institution: Tel Aviv University
Email: ronitsf@tauex.tau.ac.il
Phone: 054-7709253
Current Role & Affiliation
Prof. Satchi-Fainaro leads a multidisciplinary research laboratory at Tel Aviv University focusing on cancer research, nanomedicine, and 3D bioprinting.
Research Focus
● Cancer dormancy and tumor-host interactions
● Nanomedicine for targeted drug delivery
● 3D bioprinting for cancer research
● Translational research for clinical applications
Current Projects Related to Pediatric Brain Tumors
● Discovery of molecular targets to interrupt tumor-host interactions
● Development of targeted nanomedicine-based therapeutic strategies (P-selectin)
Laboratory/Research Resources
● Nanomedicine development platforms
● 3D bioprinting and bioengineering tools
Collaboration Interests
● Cancer nanomedicine and drug delivery
● Translational research for pediatric brain tumors
What You Can Offer Potential Collaborators
● Expertise in targeted drug delivery systems
● Advanced 3D bioprinting technologies
Selected Achievements
● Over 160 publications and 13 book chapters
● Named inventor on 95 patents, some licensed to pharmaceutical and biotech companies
● Founder of 3 spin-off companies
● Initiator of 2 clinical trials
Recent Relevant Publications
1. Koshrovski-Michael S, Ajamil DR, Dey P, Kleiner R, Tevet S, Epshtein Y, Green Buzhor M, Khoury R, Pozzi S, Shenbach-Koltin G, Yeini E, Woythe L, Blau R, Scomparin A, Barshack I, Florindo HF, Lazar S, Albertazzi L, Amir RJ, Satchi-Fainaro R. Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin-expressing cancers.Sci Adv. 2024 Dec 13;10(50):eadr4762. doi: 10.1126/sciadv.adr4762. Epub 2024 Dec 13.
2. Israeli Dangoor S, Khoury R, Salomon K, Pozzi S, Shahar S, Miari A, Leichtmann-Bardoogo Y, Bar-Hai N, Frommer N, Yeini E, Winkler T, Balint Lahat N, Kamer I, Hadad O, Laue K, Brem H, Hyde TM, Bar J, Barshack I, Ben-David U, Ishay-Ronen D, Maoz BM, Satchi-Fainaro R.CCL2 blockade combined with PD-1/P-selectin immunomodulators impedes breast cancer brain metastasis.Brain. 2024 Oct 25:awae347. doi: 10.1093/brain/awae347.
Keywords
Cancer Dormancy, Nanomedicine, 3D Bioprinting, Tumor-Host Interactions,
P- selectin
Brief Bio
Prof. Ronit Satchi-Fainaro is an internationally recognized expert in cancer research and nanomedicine. Her multidisciplinary research integrates biology, chemistry, engineering, and bioinformatics to develop targeted therapies. She has founded multiple spin-off companies and leads pioneering research in 3D bioprinting for cancer applications.
